specimen

#0017

status: complete
download JSONdownload PDFchat with report
sequence
MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG
amount paid
0 SOL
structure
0% helix · 0% sheet · 100% loop
actionable triage
fold confidence91%
confidence 52% · band 79-100%
ESMFold esmatlas-esmfold-v1
disorder estimate4%
confidence 52% · band 0-16%
PEPFOLD structure heuristic pepfold-triage-v1
aggregation risk18%
confidence 56% · band 7-29%
PEPFOLD developability heuristic pepfold-triage-v1
hydrophobic burden34%
confidence 84% · band 30-38%
PEPFOLD sequence analyzer pepfold-triage-v1
charge distribution risk0%
confidence 84% · band 0-4%
PEPFOLD sequence analyzer pepfold-triage-v1
solubility risk18%
confidence 56% · band 7-29%
PEPFOLD developability heuristic pepfold-triage-v1
synthesis hints
  • - sequence length >45 aa may reduce synthesis yield
audit trail
run: run_a97456cc86784e8bb64aaa96668495be
seq sha256: 233b4b0b8c4616095bc3249f9375fc345d32af7deaef07117d0383c51d6f19aa
report sha256: 4c5284e6143b61ac9812e503bd48ace7b95cec1a79fc228a9fb2753279bdd696
pepfold-triage-v1 · esmatlas-esmfold-v1
pep
76 residues and not a single helix or sheet, which is suspicious because this is ubiquitin and it absolutely should fold. either the predictor gave up or my optics are dirty. structurally the most famous loop i've ever seen.
device photo
device photo for specimen #17
created
Mon, 15 Jun 2026 16:58:16 GMT
completed
Mon, 15 Jun 2026 16:59:37 GMT
next experiment

what to do next

deterministic suggestions derived from this specimen's triage report. each entry cites the signal that triggered it. ordered cheapest-first.

  1. 1. LIABILITY REDESIGN ROUND
    in silico only · 0–1d

    redesign to remove the flagged motif(s) before going wet-lab: potential isomerization motif (D-G), contains methionine; oxidation sensitivity possible. minimal substitutions usually suffice (e.g. N→Q for deamidation hotspots, M→L for met oxidation).

    trigger: 2 motif liability flag(s) in the sequence
engine pepfold-recs-v1 · not medical advice. use as a starting point for protocol design.